Cranbrook Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Cranbrook Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.3K	Hold	1,313	–	–	﹤0.01%	231
2025 Q4	$20.5K	Hold	1,313	–	–	﹤0.01%	245
2025 Q3	$19.2K	Hold	1,313	–	–	﹤0.01%	258
2025 Q2	$20.3K	Hold	1,313	–	–	﹤0.01%	247
2025 Q1	$19.5K	Hold	1,313	–	–	﹤0.01%	232
2024 Q4	$17.4K	Hold	1,313	–	–	﹤0.01%	235
2024 Q3	$18.7K	Hold	1,313	–	–	﹤0.01%	228
2024 Q2	$17K	Hold	1,313	–	–	﹤0.01%	228
2024 Q1	$18.2K	Hold	1,313	–	–	﹤0.01%	206
2023 Q4	$18.7K	Hold	1,313	–	–	0.01%	204
2023 Q3	$20.3K	Hold	1,313	–	–	0.01%	187
2023 Q2	$20.6K	Hold	1,313	–	–	0.01%	194
2023 Q1	$21.6K	Hold	1,313	–	–	0.01%	196
2022 Q4	$20.5K	Hold	1,313	–	–	0.01%	194
2022 Q3	$17K	Hold	1,313	–	–	﹤0.01%	219
2022 Q2	$18K	Hold	1,313	–	–	﹤0.01%	220
2022 Q1	$19K	Hold	1,313	–	–	﹤0.01%	244
2021 Q4	$18K	Hold	1,313	–	–	﹤0.01%	245
2021 Q3	$22K	Hold	1,313	–	–	0.01%	249
2021 Q2	$22K	Hold	1,313	–	–	0.01%	236
2021 Q1	$24K	Hold	1,313	–	–	0.01%	232
2020 Q4	$24K	Hold	1,313	–	–	0.01%	197
2020 Q3	$23K	Hold	1,313	–	–	0.01%	177
2020 Q2	$24K	Hold	1,313	–	–	0.01%	170
2020 Q1	$20K	Hold	1,313	–	–	0.01%	167
2019 Q4	$26K	Hold	1,313	–	–	0.01%	167
2019 Q3	$23K	Hold	1,313	–	–	0.01%	164
2019 Q2	$23K	Hold	1,313	–	–	0.01%	162
2019 Q1	$27K	Buy	+1,313	New	+$26.4K	0.01%	160

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cranbrook Wealth Management's TAK Position: Q1 2026 in Review

Cranbrook Wealth Management held its Takeda Pharmaceutical (TAK) position steady in Q1 2026 at 1,313 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #231.

Cranbrook Wealth Management first reported a position in TAK in Q1 2019 and has held it in 29 quarters since. The position peaked at $27K in Q1 2019. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Cranbrook Wealth Management held 1,313 shares of Takeda Pharmaceutical worth $24.3K as of Q1 2026.
Cranbrook Wealth Management left its Takeda Pharmaceutical share count unchanged in Q1 2026.
Takeda Pharmaceutical made up ﹤0.01% of Cranbrook Wealth Management's portfolio in Q1 2026, its #231 holding.
Cranbrook Wealth Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 29 quarters since.
Cranbrook Wealth Management's Takeda Pharmaceutical position peaked at $27K in Q1 2019.
358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Cranbrook Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.